Drug recall · January 1, 2014
Tacrolimus Capsules recall
Why: Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01
- Lots / codes
Lots DE9898, DE9900, DE9903, DE9908, DE9911. Exp. 06/14
- Quantity
- 12,521 bottles
- Company
- Sandoz Incorporated, Broomfield, CO
- Distribution
- Nationwide
- Initiated
- October 22, 2013 · Voluntary: Firm initiated
- Classified
- December 20, 2013
- Reported
- January 1, 2014
- Ended
- July 10, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tacrolimus
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.